SCHEMBL15534613

SCHEMBL15534613

CC(C)(C)OC(=O)N1CCN(c2ccc3cccc(F)c3c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.56
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
GPR119 Q8TDV5 7/20 0.51
BACE1 P56817 1/20 0.48
NAMPT P43490 1/20 0.48
ALK Q9UM73 1/20 0.47
ACHE P22303 1/20 0.46
SOS1 Q07889 1/20 0.45
CXCR2 P25025 1/20 0.45
JAK2 O60674 1/20 0.45
JAK3 P52333 1/20 0.45
MEN1 O00255 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373904 0.83 BACE1 (0.51) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL20159003 0.82 MAPT (0.59) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL5366413 0.82 BACE1 (0.49) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL2386747 0.81 GPR119 (0.59) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL24124829 0.80 MAPT (0.56) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL5366552 0.80 TP53 (0.49) ALDH1A1LMNAMAPTGPR119BACE1
SCHEMBL14992693 0.80 MAPT (0.56) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL5256454 0.80 MAPT (0.56) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL21995916 0.80 TP53 (0.49) PDK2ALDH1A1LMNAMAPTGPR119
SCHEMBL30992952 0.80 MAPT (0.51) PDK2ALDH1A1LMNAMAPTGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013177253-A2 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-11-28 WO disclosed